 |
5 Diseases |  |
0 Trials |
|
0 Trials |  |
2 News |  |
- | MK-8655 / Merck (MSD)
Trial completion: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MK-8655 in Participants With Type 2 Diabetes (MK-8655-002) (clinicaltrials.gov) - Jan 7, 2013
P1, N=33, Completed, Sponsor: Merck Sharp & Dohme Corp.
Active, not recruiting --> Completed
- | MK-8655 / Merck (MSD)
New P1 trial: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MK-8655 in Participants With Type 2 Diabetes (MK-8655-002) (clinicaltrials.gov) - Jul 12, 2012
P1, N=33, Completed, Sponsor: Merck Sharp & Dohme Corp.